3-hydroxybutyric acid has been researched along with Critical Illness in 8 studies
3-Hydroxybutyric Acid: BUTYRIC ACID substituted in the beta or 3 position. It is one of the ketone bodies produced in the liver.
3-hydroxybutyric acid : A straight-chain 3-hydroxy monocarboxylic acid comprising a butyric acid core with a single hydroxy substituent in the 3- position; a ketone body whose levels are raised during ketosis, used as an energy source by the brain during fasting in humans. Also used to synthesise biodegradable plastics.
Critical Illness: A disease or state in which death is possible or imminent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Muscle weakness is a complication of critical illness which hampers recovery." | 1.62 | Altered cholesterol homeostasis in critical illness-induced muscle weakness: effect of exogenous 3-hydroxybutyrate. ( Derde, S; Derese, I; Ghesquière, B; Goossens, C; Langouche, L; Van den Berghe, G; Van Veldhoven, PP; Vander Perre, S; Weckx, R, 2021) |
| "The 'obesity paradox' of critical illness refers to better survival with a higher body mass index." | 1.46 | Premorbid obesity, but not nutrition, prevents critical illness-induced muscle wasting and weakness. ( De Bock, K; Derde, S; Dufour, T; Goossens, C; Güiza, F; Hermans, G; Janssens, T; Langouche, L; Marques, MB; Thiessen, SE; Van den Berghe, G; Vander Perre, S; Vanhorebeek, I, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gunst, J | 1 |
| De Bruyn, A | 1 |
| Casaer, MP | 1 |
| Vander Perre, S | 3 |
| Langouche, L | 3 |
| Van den Berghe, G | 3 |
| Goossens, C | 2 |
| Weckx, R | 1 |
| Derde, S | 2 |
| Derese, I | 1 |
| Van Veldhoven, PP | 1 |
| Ghesquière, B | 1 |
| Marques, MB | 1 |
| Dufour, T | 1 |
| Thiessen, SE | 1 |
| Güiza, F | 1 |
| Janssens, T | 1 |
| Hermans, G | 1 |
| Vanhorebeek, I | 1 |
| De Bock, K | 1 |
| Taboulet, P | 1 |
| Haas, L | 1 |
| Porcher, R | 1 |
| Manamani, J | 1 |
| Fontaine, JP | 1 |
| Feugeas, JP | 1 |
| Gautier, JF | 1 |
| Bektas, F | 1 |
| Eray, O | 1 |
| Sari, R | 1 |
| Akbas, H | 1 |
| Ball, MJ | 1 |
| Willis, N | 1 |
| Mogridge, J | 1 |
| Yassen, KA | 1 |
| Galley, HF | 1 |
| Lee, A | 1 |
| Webster, NR | 1 |
3 trials available for 3-hydroxybutyric acid and Critical Illness
| Article | Year |
|---|---|
Impact of tight glucose control on circulating 3-hydroxybutyrate in critically ill patients.
Topics: 3-Hydroxybutyric Acid; Adult; Child; Critical Illness; Glycemic Control; Humans; Insulins | 2021 |
Point of care blood ketone testing of diabetic patients in the emergency department.
Topics: 3-Hydroxybutyric Acid; Adolescent; Adult; Aged; Critical Illness; Diabetes Complications; Diabetes M | 2004 |
Parenteral nutrition in the critically ill: use of a medium chain triglyceride emulsion.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Adult; Aged; Blood Cell Count; Carnitine; Critical Illness; Dr | 1993 |
5 other studies available for 3-hydroxybutyric acid and Critical Illness
| Article | Year |
|---|---|
Altered cholesterol homeostasis in critical illness-induced muscle weakness: effect of exogenous 3-hydroxybutyrate.
Topics: 3-Hydroxybutyric Acid; Aged; Aged, 80 and over; Animals; Cholesterol; Critical Illness; Disease Mode | 2021 |
Premorbid obesity, but not nutrition, prevents critical illness-induced muscle wasting and weakness.
Topics: 3-Hydroxybutyric Acid; Aged; Animals; Body Composition; Critical Illness; Fasting; Fatty Acids; Fema | 2017 |
Urinary acetoacetate or capillary beta-hydroxybutyrate for the diagnosis of ketoacidosis in the Emergency Department setting.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Biomarkers; Capillaries; Critical Illness; Diabetic Ketoacidos | 2004 |
Indicators of histohypoxia.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Carbon Dioxide; Cardiac Output; Cell Hypoxia; Cell Survival; C | 1995 |
Mitochondrial redox state in the critically ill.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Adult; Aged; Biomarkers; Critical Illness; Humans; Ketone Bodi | 1999 |